November 2015


This November is #COPDAwarenessMonth. We are hosting several seminars in Scottsdale, Arizona, Pittsburgh, Pennsylvania,Nashville, Tennessee and Tampa, Florida. If you are near any of these locations, we invite you to join us to learn more about the therapies we offer for lung disease.

For more information about these and other upcoming events, visit our event calendar.

This month, we have three blogs to highlight our focus on COPD and you can find a link to each one below.

Helping you breathe easier,

Lung Institute 


Do you know that November is COPD Awareness Month, and World COPD Day is November 18, 2015? COPD is more common than you might think. It’s time to engage in the movement to bring greater awareness to COPD and treatment options. So, how well do you know COPD?



Cold weather can cause difficulties for anyone, but for people with COPD, changes in the weather can affect their health. Whether it is too hot or too cold, these changes can trigger symptoms. There are many reasons you have to brave the cold, such as going to work, walking to your car or enjoying the outdoors. Thankfully, there are ways for you and your lungs to stay warmer.



Upon being diagnosed with chronic obstructive pulmonary disease (COPD), and shortly before death on Feb. 27, 2015, actor Leonard Nimoy tweeted, “Not soon enough.” He was referring to his decision to quit smoking. Nimoy, made famous by playing Spock in Star Trek, had quit 30 years before, but the damage to his lungs had already been done…


* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.